Lineage cell therapeutics announces extension of opregen® development grant from israel innovation authority

Lineage cell therapeutics, inc. (nyse american and tase: lctx), a clinical-stage biotechnology company developing novel cell therapies for unmet medic

BCLI Ratings Summary

BCLI Quant Ranking